For generations, a genetic predisposition to iron overload has been known to disproportionately affect people of Celtic ancestry, earning it the nickname “Celtic curse.” Now, a groundbreaking novel study has pinpointed specific geographic hotspots across the UK and Ireland where the risk of hemochromatosis – a condition where the body absorbs too much iron – is significantly elevated. The research, published in Nature Communications, reveals that as many as one in 54 people in northwest Ireland carry a gene variant linked to the disorder, while in the Outer Hebrides of Scotland, the rate is approximately one in 62. Understanding these regional concentrations of genetic risk is a crucial step toward earlier diagnosis and prevention of a potentially life-threatening illness.
Hemochromatosis, if left untreated, can lead to a buildup of iron in organs like the liver, heart, and pancreas, causing serious complications including liver damage, liver cancer, arthritis, and diabetes. Early symptoms can be vague – fatigue, joint pain – making diagnosis challenging. But, a simple blood test can identify the condition, and treatment, often involving regular blood donation (phlebotomy), is highly effective in managing iron levels and preventing long-term damage. This new mapping of genetic risk for hemochromatosis, sometimes called the ‘Celtic curse’, is the first of its kind across the UK and Ireland, and promises to refine screening efforts.
Mapping the Genetic Landscape of Iron Overload
Researchers at the University of Edinburgh analyzed genetic data from over 400,000 participants in the UK BioBank and Viking Genes studies to determine the prevalence of the C282Y gene variant, the most common genetic factor contributing to hemochromatosis in these populations. The study examined 29 regions across the British Isles and Ireland, revealing a clear pattern of geographic clustering. Beyond northwest Ireland and the Outer Hebrides, Northern Ireland also showed a higher-than-average risk, with approximately one in 71 individuals carrying the variant. Mainland Scotland, particularly Glasgow and southwest Scotland, also exhibited elevated risk, at a rate of about one in 117.
The findings underscore the long-held belief that individuals with Celtic ancestry are at increased risk. However, the detailed mapping now allows for a more targeted approach to screening. “Given that the combined genetic risk is so high in these regions, researchers say targeted screening there would likely identify the greatest number of people with the condition,” according to the study’s findings.
Diagnosis Disparities and the Impact of Migration
An analysis of National Health Service (NHS) England records revealed more than 70,000 diagnosed cases of hemochromatosis. Notably, individuals of White Irish descent were nearly four times more likely to receive a diagnosis compared to those of White British descent. This disparity doesn’t necessarily indicate a higher prevalence of the condition in the Irish population, but rather highlights potential differences in awareness, access to healthcare, or diagnostic practices.
Intriguingly, within England, diagnosis rates varied significantly by region. Individuals living in Liverpool were 11 times more likely to be diagnosed with hemochromatosis than those in Kent. Researchers suggest this difference may be linked to historical migration patterns, noting that over 20 percent of Liverpool’s population had Irish roots in the 1850s. ScienceDaily reports that this pattern suggests a legacy effect of population movement on current diagnosis rates.
While diagnosis rates generally mirrored genetic risk across England, some areas – Birmingham, Cumbria, Northumberland, and Durham – reported fewer cases than expected based on their genetic profiles. These regions may represent areas where undiagnosed cases are prevalent, and where expanded screening efforts could be particularly beneficial. Data from Scotland, Wales, and Northern Ireland were not available for this portion of the analysis.
Calls for Community-Wide Screening and Increased Awareness
The study’s findings have prompted calls for community-wide genetic screening in high-risk areas. Professor Jim Flett Wilson, Chair of Human Genetics at the University of Edinburgh, emphasized the importance of early detection. “If untreated, the iron-overload disease hemochromatosis can lead to liver cancer, arthritis and other poor outcomes,” he said. “We have shown that the risk in the Hebrides and Northern Ireland is much higher than previously thought, with about one in every 60 people at risk, about half of whom will develop the disease. Early detection prevents most of the adverse consequences and a simple treatment — giving blood — is available. The time has come to plan for community-wide genetic screening in these high-risk areas, to identify as many people as possible whose genes mean they are at high risk of this preventable illness.”
Jonathan Jelley MBE JP, CEO of Haemochromatosis UK, echoed this sentiment, stating that the research “has the potential to lead to greater targeted awareness, increased diagnosis and better treatment pathways for thousands of people affected by genetic hemochromatosis.” The charity is already prioritizing hotspot areas for support, including through its National Helpline and clinician education programs. SciTechDaily highlights the charity’s commitment to advocating for increased public resources for this often-overlooked condition.
Torcuil Crichton, the Labour MP for Na h-Eileanan an Iar (the Western Isles), who himself has hemochromatosis, is actively advocating for screening in his constituency. “This research writes the case for community-wide screening in the Western Isles, Northern Ireland, and other hemochromatosis hotspots,” Crichton stated. “I have previously raised this with Ministers in the House of Commons and this new evidence ought to be enough to persuade the UK National Screening Committee to review its position and approve a pilot screening program.”
The UK National Screening Committee will be reviewing the evidence presented in the study. The next step will be a formal assessment of the feasibility and cost-effectiveness of implementing a targeted screening program in high-risk regions. For individuals with a family history of hemochromatosis or who live in one of the identified hotspots, discussing genetic testing with a healthcare provider is recommended. Early detection remains the most effective strategy for preventing the serious health consequences associated with this treatable, yet often overlooked, genetic condition.
Do you have personal experience with hemochromatosis or a family history of the condition? Share your thoughts in the comments below, and please share this article with anyone who might benefit from this information.
